Literature DB >> 20816214

Galectin-1 and HIV-1 Infection.

Christian St-Pierre1, Michel Ouellet, Michel J Tremblay, Sachiko Sato.   

Abstract

Initial binding of human immunodeficiency virus-1 (HIV-1) to its susceptible CD4(+) cells is the limiting step for the establishment of infection as the avidity of viral envelope gp120 for CD4 is not high and the number of viral envelope spikes on the surface is found to be low compared to highly infectious viruses. Several host factors, such as C-type lectins, are listed as being able to enforce or facilitate the crucial interaction of HIV-1 to the susceptible cell. Recent works suggest that a host soluble beta-galactoside-binding lectin, galectin-1, also facilitates both virion binding and the infection of target cells in a manner dependent on lactose but not mannose, suggesting that this soluble galectin can be considered as a host factor that influences HIV-1 pathogenesis. In this chapter, we describe methods used to investigate the potential role of the galectin family in HIV-1-mediated disease progression. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20816214     DOI: 10.1016/S0076-6879(10)80013-8

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  16 in total

1.  Nanoparticle based galectin-1 gene silencing, implications in methamphetamine regulation of HIV-1 infection in monocyte derived macrophages.

Authors:  Jessica L Reynolds; Wing Cheung Law; Supriya D Mahajan; Ravikumar Aalinkeel; Bindukumar Nair; Donald E Sykes; Ken-Tye Yong; Rui Hui; Paras N Prasad; Stanley A Schwartz
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-12       Impact factor: 4.147

2.  Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection.

Authors:  Christian St-Pierre; Michel Ouellet; Denis Giguère; Reiko Ohtake; René Roy; Sachiko Sato; Michel J Tremblay
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

3.  Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate.

Authors:  Jieyun Jiang; Wei Cun; Xianfang Wu; Qing Shi; Hengli Tang; Guangxiang Luo
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

4.  Host-soluble galectin-1 promotes HIV-1 replication through a direct interaction with glycans of viral gp120 and host CD4.

Authors:  Christian St-Pierre; Hiroshi Manya; Michel Ouellet; Gary F Clark; Tamao Endo; Michel J Tremblay; Sachiko Sato
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

5.  Morphine and galectin-1 modulate HIV-1 infection of human monocyte-derived macrophages.

Authors:  Jessica L Reynolds; Wing Cheung Law; Supriya D Mahajan; Ravikumar Aalinkeel; Bindukumar Nair; Donald E Sykes; Manoj J Mammen; Ken-Tye Yong; Rui Hui; Paras N Prasad; Stanley A Schwartz
Journal:  J Immunol       Date:  2012-03-19       Impact factor: 5.422

6.  Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages.

Authors:  Irena Kadiu; Prabagaran Narayanasamy; Prasanta K Dash; Wei Zhang; Howard E Gendelman
Journal:  J Immunol       Date:  2012-06-18       Impact factor: 5.422

7.  Galectin-1 Reduces Neuroinflammation via Modulation of Nitric Oxide-Arginase Signaling in HIV-1 Transfected Microglia: a Gold Nanoparticle-Galectin-1 "Nanoplex" a Possible Neurotherapeutic?

Authors:  Ravikumar Aalinkeel; Courtney S Mangum; Eliane Abou-Jaoude; Jessica L Reynolds; Maixian Liu; Karin Sundquist; Neil U Parikh; Lee D Chaves; Manoj J Mammen; Stanley A Schwartz; Supriya D Mahajan
Journal:  J Neuroimmune Pharmacol       Date:  2016-12-27       Impact factor: 4.147

Review 8.  Affinofile profiling: how efficiency of CD4/CCR5 usage impacts the biological and pathogenic phenotype of HIV.

Authors:  Kelechi Chikere; Tom Chou; Paul R Gorry; Benhur Lee
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

9.  Galectin-1 interacts with the human endogenous retroviral envelope protein syncytin-2 and potentiates trophoblast fusion in humans.

Authors:  Caroline Toudic; Amandine Vargas; Yong Xiao; Guillaume St-Pierre; Norbert Bannert; Julie Lafond; Éric Rassart; Sachiko Sato; Benoit Barbeau
Journal:  FASEB J       Date:  2019-09-07       Impact factor: 5.191

10.  Galectin-3 and N-acetylglucosamine promote myogenesis and improve skeletal muscle function in the mdx model of Duchenne muscular dystrophy.

Authors:  Ann Rancourt; Sébastien S Dufresne; Guillaume St-Pierre; Julie-Christine Lévesque; Haruka Nakamura; Yodai Kikuchi; Masahiko S Satoh; Jérôme Frenette; Sachiko Sato
Journal:  FASEB J       Date:  2018-06-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.